Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.3M Buy
12,649
+2,852
+29% +$291K 0.01% 884
2025
Q4
$985K Sell
9,797
-3,042
-24% -$300K 0.01% 956
2025
Q3
$1.11M Buy
12,839
+1,976
+18% +$156K 0.01% 890
2025
Q2
$829K Buy
10,863
+288
+3% +$21.1K 0.01% 951
2025
Q1
$750K Sell
10,575
-475
-4% -$37.1K 0.01% 1010
2024
Q4
$865K Buy
11,050
+1,040
+10% +$97.1K 0.01% 987
2024
Q3
$1.02M Buy
10,010
+197
+2% +$16.3K 0.01% 1090
2024
Q2
$744K Buy
+9,813
New +$698K 0.01% 1255

Other funds holding NUVL

Guggenheim Capital's NUVL Position: Q1 2026 in Review

Guggenheim Capital increased its Nuvalent (NUVL) stake by 29% in Q1 2026, buying an estimated $291K and bringing the position to 12,649 shares worth $1.3M. The position accounts for 0.01% of the portfolio, ranked #884.

Guggenheim Capital first reported a position in NUVL in Q2 2024 and has held it in 8 quarters since. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Guggenheim Capital held 12,649 shares of Nuvalent worth $1.3M as of Q1 2026.
  • Guggenheim Capital bought 2,852 Nuvalent shares in Q1 2026, an estimated $291K.
  • Nuvalent made up 0.01% of Guggenheim Capital's portfolio in Q1 2026, its #884 holding.
  • Guggenheim Capital first reported a position in Nuvalent in Q2 2024 and has held it in 8 quarters since.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.